IRWD logo

Ironwood Pharmaceuticals, Inc. - Class A

IRWD

IRWD: Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

more

Show IRWD Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of IRWD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by IRWD's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Stable formulations of linaclotide Jul. 07, 2020
  • Patent Title: Stable formulations of linaclotide Jun. 09, 2020
  • Patent Title: Sgc stimulators Jan. 29, 2019
  • Patent Title: Sgc stimulators Jan. 22, 2019
  • Patent Title: Sgc stimulators Aug. 14, 2018
  • Patent Title: Imidazotriazinone compounds May. 15, 2018
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Dec. 12, 2017
  • Patent Title: Imidazotriazinone compounds Aug. 08, 2017
  • Patent Title: Treatments for gastrointestinal disorders Jul. 18, 2017
  • Patent Title: Faah inhibitors May. 23, 2017
  • Patent Title: Treatments for gastrointestinal disorders May. 16, 2017
  • Patent Title: Treatments for gastrointestinal disorders Apr. 11, 2017
  • Patent Title: Sgc stimulators Mar. 07, 2017
  • Patent Title: Imidazotriazinone compounds Jan. 10, 2017
  • Patent Title: Treatments for gastrointestinal disorders Dec. 27, 2016
  • Patent Title: Sgc stimulators Nov. 08, 2016
  • Patent Title: Sgc stimulators Nov. 01, 2016
  • Patent Title: Sgc stimulators Apr. 12, 2016
  • Patent Title: Treatments for gastrointestinal disorders Apr. 05, 2016
  • Patent Title: Compositions comprising bile acid sequestrants for treating esophageal disorders Dec. 08, 2015
  • Patent Title: 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators Sep. 22, 2015
  • Patent Title: Sgc stimulators Jun. 23, 2015
  • Patent Title: Nonoate derivatives and uses thereof May. 05, 2015
  • Patent Title: Treatments of gastrointestinal disorders Feb. 03, 2015
  • Patent Title: Indole compounds Nov. 11, 2014
  • Patent Title: Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration Aug. 12, 2014
  • Patent Title: Methods and compositions for the treatment of heart failure and other disorders Jul. 15, 2014
  • Patent Title: Formulations comprising linaclotide Jun. 10, 2014
  • Patent Title: Sgc stimulators Jun. 10, 2014
  • Patent Title: Treatments for gastrointestinal disorders May. 27, 2014
  • Patent Title: Crth2 modulators Mar. 18, 2014
  • Patent Title: Treatments for gastrointestinal disorders Aug. 13, 2013
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Feb. 07, 2012
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Jan. 24, 2012
  • Patent Title: Compounds and methods for the treatment of asthma Jan. 03, 2012
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Dec. 20, 2011
  • Patent Title: Useful indole compounds Jun. 14, 2011
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Mar. 22, 2011
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Aug. 10, 2010
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Jun. 29, 2010
  • Patent Title: Methods and compositions for the treatment of gastrointestinal disorders Apr. 27, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of IRWD in WallStreetBets Daily Discussion

IRWD News

Recent insights relating to IRWD

CNBC Recommendations

Recent picks made for IRWD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IRWD

Corporate Flights

Flights by private jets registered to IRWD